Polyp Gossip – Episode 8
Can remission become the new benchmark in CRSwNP care? In this episode, our expert panel explores the evolving treatment landscape and what "remission" truly means for patients and clinicians. Join us as we look ahead to a future beyond symptom control - where long-term outcomes and deeper disease understanding could transform the way we define treatment success.
PREVIOUS EPISODE
Polyp Gossip Episode 8: The Future of CRSwNP Treatment: Aiming for remission
Can remission become the new benchmark in CRSwNP care? In this episode, our expert panel explores the evolving treatment landscape and what "remission" truly means for patients and clinicians. Join us as we look ahead to a future beyond symptom control - where long-term outcomes and deeper disease understanding could transform the way we define treatment success.
Expert panel
|
Anju Peter MD, PhD |
|
Stella Lee MD, PhD |
|
Peter Hellings MD, PhD |
Previous episodes
Biography
Peter Hellings
Peter W. Hellings, MD, PhD, is a Professor and Clinic Head at the Department of Otorhinolaryngology at the University Hospitals of Leuven, and a Guest Professor at Ghent University, Belgium.
Prof. Hellings' research has led to novel insights into the pathophysiology of allergy and chronic airway inflammation, with over 350 scientific publications in top journals in the field of allergology, rhinology, and respiratory care. He is the founder of the European Forum for Research and Education in Allergy and Airway Diseases, an international nonprofit involving a consortium of European key opinion leaders aiming at the implementation of optimal care for chronic respiratory diseases. He is also the founder and director of the European Rhinoplasty Course and a member of European and American guideline committees.

